-
Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply
CROSSFIRE study investigators, 1 Aug 2024, In: The Lancet Gastroenterology and Hepatology. 9, 8, p. 687-688 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
-
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
Timmer, F. E. F., Geboers, B., Ruarus, A. H., Vroomen, L. G. P. H., Schouten, E. A. C., van der Lei, S., Vos, D. J. W., Dijkstra, M., Schulz, H. H., Bakker, J., van den Bemd, B. A. T., van den Tol, P. M., Puijk, R. S., Lissenberg-Witte, B. I., de Gruijl, T. D., de Vries, J. J. J., Lagerwaard, F. J., Scheffer, H. J., Bruynzeel, A. M. E. & Meijerink, M. R., 1 May 2024, In: The Lancet Gastroenterology and Hepatology. 9, 5, p. 448-459 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Local Treatment of Colorectal Liver Metastases in the Presence of Extrahepatic Disease: Survival Outcomes from the Amsterdam Colorectal Liver Met Registry (AmCORE)
Schulz, H. H., Dijkstra, M., van der Lei, S., Vos, D. J. W., Timmer, F. E. F., Puijk, R. S., Scheffer, H. J., van den Tol, M. P., Lissenberg-Witte, B. I., Buffart, T. E., Versteeg, K. S., Swijnenburg, R-J. & Meijerink, M. R., 1 Mar 2024, In: Cancers. 16, 6, 1098.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
